logo

Eli Lilly $5 Billion Manufacturing Facility in Richmond, Virginia

Planned · Virginia · Last reported Sep 2025

Source: BioSpace

Project
Planned

Eli Lilly plans to construct a $5 billion manufacturing facility in Richmond, Virginia, to produce bioconjugate and antibody therapies, focusing on monoclonal antibody and antibody-drug conjugate therapies for cancer and immune-mediated indications. The facility will incorporate advanced technologies such as automated systems and artificial intelligence. The project is expected to create 2,450 job

Status
Prospective
Sector
Manufacturing (Industrial)
Location
Richmond, Virginia, United States of America
Updated
22 Jul 2026
Source
BioSpace

ConstructChat

Ask ConstructChat about Eli Lilly $5 Billion Manufacturing Facility in Richmond, Virginia

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “Eli Lilly $5 Billion Manufacturing Facility in Richmond, Virginia” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Richmond, Virginia, United States. Taiyo aggregates data on it from BioSpace.

Participants

Not available for this record.

Status

Original status

planned

Taiyo status

Prospective

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Eli Lilly plans to construct a $5 billion manufacturing facility in Richmond, Virginia, to produce bioconjugate and antibody therapies, focusing on monoclonal antibody and antibody-drug conjugate therapies for cancer and immune-mediated indications. The facility will incorporate advanced technologies such as automated systems and artificial intelligence. The project is expected to create 2,450 jobs and be completed within five years.

Original sector

Manufacturing

Budget

Location

Country

United States of America (USA)

State

Virginia

City

Richmond

Source

Source

BioSpace

URL

More Details

Record type

Project

Sector

Manufacturing (Industrial)

Article published date

2025-09-20

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project